Bio Protocol vs Jupiter — how do they compare? Bio Protocol trades at Rp442.16 (market cap Rp999,88M, Rp161,38M 24h volume), while Jupiter trades at Rp3,000 (market cap Rp9,96T, Rp284,84M 24h volume). The key difference: Jupiter is far larger — about 9961.2× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 3,3B / 6,9B JUP (49%) for Jupiter. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Jupiter for 37 Days on average.
| BIO | JUP | |
|---|---|---|
Market Cap | Rp999,88M | Rp9,96T |
Volume (24h) | Rp161,38M | Rp284,84M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 3,3B / 6,9B JUP (49%) |
Typical Hold Time | 18 Days | 37 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Jupiter (JUP) is trading at Rp3,063 with a market cap of Rp10.05 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The asset has a circulating supply of 3.3 million out of 6.9 million tokens, with 49% in circulation and an average hold time of 37 days. Support and resistance levels suggest key price zones for monitoring.
Overall outlook is cautious due to bearish technicals and limited recent ecosystem updates. Opportunities include potential oversold conditions from RSI levels, while risks involve low liquidity and high volatility. Investors should watch for network activity changes and regulatory developments.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →As one of the industry's most advanced swap aggregation engines, Jupiter excels in delivering essential liquidity infrastructure for the Solana ecosystem. Moreover, Jupiter is actively expanding its DeFi product offerings, featuring a comprehensive suite that includes Limit Order, DCA/TWAP, Bridge Comparator, and Perpetuals Trading.
Read more on JUP →